Mutations in the AXIN1 Gene in Advanced Prostate Cancer
β Scribed by George W. Yardy; David C. Bicknell; Jennifer L. Wilding; Sylvia Bartlett; Ying Liu; Bruce Winney; Gareth D.H. Turner; Simon F. Brewster; Walter F. Bodmer
- Book ID
- 113610860
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 701 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0302-2838
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Axin is a recently identified tumor suppressor that plays an important role in liver and colon cancers. To gain further insights into the structure and function of Axin in controlling cell growth, we analyzed 54 colorectal cancer tissues for mutations in AXIN1 gene. We employed PCR ampl
Gene amplification is a model of proto-oncogene alterations occasionally observed in human tumors. This amplification can, in some cases, have prognostic value (N-myc in neuroblastoma, c-erbB2 and int-2 in breast cancer, etc.). Amplifications of the proto-oncogenes c-myc, c-erbB2 and int-2 have not
The MSR1 gene at 8p22 has been suggested as a candidate gene for hereditary prostate cancer because germline variants have been found to be associated with the disease. Aside from a single nonsense mutation (R293X) that was found repeatedly at low frequencies in several samples, little evidence has